• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Healthy lifestyle factors and risk of cardiovascular events and mortality in treatment-resistant hypertension: the Reasons for Geographic and Racial Differences in Stroke study.健康生活方式因素与治疗抵抗性高血压患者心血管事件和死亡风险:卒中地理和种族差异研究。
Hypertension. 2014 Sep;64(3):465-71. doi: 10.1161/HYPERTENSIONAHA.114.03565. Epub 2014 Jun 9.
2
Underutilization of Treatment for Black Adults With Apparent Treatment-Resistant Hypertension: JHS and the REGARDS Study.黑人成年人中明显治疗抵抗性高血压治疗不足:JHS 和 REGARDS 研究。
Hypertension. 2020 Nov;76(5):1600-1607. doi: 10.1161/HYPERTENSIONAHA.120.14836. Epub 2020 Sep 14.
3
Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).抗高血压和降脂治疗预防心脏病发作试验(ALLHAT):治疗抵抗性高血压与心血管疾病和终末期肾病的发病率。
Hypertension. 2014 Nov;64(5):1012-21. doi: 10.1161/HYPERTENSIONAHA.114.03850. Epub 2014 Aug 4.
4
Cardiovascular Health and Transition From Controlled Blood Pressure to Apparent Treatment Resistant Hypertension: The Jackson Heart Study and the REGARDS Study.心血管健康与血压控制达标到血压明显难治的转变:杰克逊心脏研究和 REGARDS 研究。
Hypertension. 2020 Dec;76(6):1953-1961. doi: 10.1161/HYPERTENSIONAHA.120.15890. Epub 2020 Nov 2.
5
The contributions of unhealthy lifestyle factors to apparent resistant hypertension: findings from the Reasons for Geographic And Racial Differences in Stroke (REGARDS) study.不健康生活方式因素对明显难治性高血压的影响:来自地理和种族差异导致中风的原因(REGARDS)研究的结果。
J Hypertens. 2013 Feb;31(2):370-6. doi: 10.1097/HJH.0b013e32835b6be7.
6
Incident ESRD and treatment-resistant hypertension: the reasons for geographic and racial differences in stroke (REGARDS) study.事件终末期肾病和治疗抵抗性高血压:中风的地理和种族差异的原因(REGARDS 研究)。
Am J Kidney Dis. 2014 May;63(5):781-8. doi: 10.1053/j.ajkd.2013.11.016. Epub 2014 Jan 1.
7
Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack.有中风或短暂性脑缺血发作病史的个体中明显的难治性高血压
Am J Med. 2015 Jul;128(7):707-14.e2. doi: 10.1016/j.amjmed.2015.02.008. Epub 2015 Mar 10.
8
Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality.貌似难治性高血压与中风、冠心病及全因死亡率风险
J Am Soc Hypertens. 2014 Jun;8(6):405-13. doi: 10.1016/j.jash.2014.03.003. Epub 2014 Mar 15.
9
Effect of sustaining lifestyle modifications (nonsmoking, weight reduction, physical activity, and mediterranean diet) after healing of myocardial infarction, percutaneous intervention, or coronary bypass (from the REasons for Geographic and Racial Differences in Stroke Study).心肌梗死后、经皮介入治疗或冠状动脉旁路手术后维持生活方式改变(不吸烟、减肥、身体活动和地中海饮食)的效果(来自地理和种族差异中风研究的原因)。
Am J Cardiol. 2014 Jun 15;113(12):1933-40. doi: 10.1016/j.amjcard.2014.03.033. Epub 2014 Apr 1.
10
Refractory Hypertension and Risks of Adverse Cardiovascular Events and Mortality in Patients With Resistant Hypertension: A Prospective Cohort Study.难治性高血压与耐药性高血压患者不良心血管事件和死亡风险:一项前瞻性队列研究。
J Am Heart Assoc. 2020 Sep;9(17):e017634. doi: 10.1161/JAHA.120.017634. Epub 2020 Aug 27.

引用本文的文献

1
Association Between Life's Essential 8 and Cardiovascular, Cancer, and Other Cause Mortality: The REGARDS Study.生命基本八项与心血管疾病、癌症及其他死因死亡率之间的关联:REGARDS研究
JACC Adv. 2025 Jun;4(6 Pt 2):101731. doi: 10.1016/j.jacadv.2025.101731. Epub 2025 May 8.
2
Cost-Effectiveness of Ultrasound Renal Denervation for Resistant Hypertension in Belgium, France and The Netherlands.比利时、法国和荷兰超声肾动脉去神经术治疗顽固性高血压的成本效益分析
Pharmacoecon Open. 2025 Apr 16. doi: 10.1007/s41669-025-00574-2.
3
Investigation and management of resistant hypertension: British and Irish Hypertension Society position statement.难治性高血压的调查与管理:英国和爱尔兰高血压学会立场声明
J Hum Hypertens. 2025 Jan;39(1):1-14. doi: 10.1038/s41371-024-00983-6. Epub 2024 Dec 9.
4
Advances in preclinical surgical therapy of cardiovascular diseases.心血管疾病临床前外科治疗的进展。
Int J Surg. 2024 Aug 1;110(8):4965-4975. doi: 10.1097/JS9.0000000000001534.
5
Cost Effectiveness of Endovascular Ultrasound Renal Denervation in Patients with Resistant Hypertension.血管内超声肾去神经术治疗顽固性高血压患者的成本效益分析
Pharmacoecon Open. 2024 Jul;8(4):525-537. doi: 10.1007/s41669-024-00472-z. Epub 2024 Jan 30.
6
Lifestyle Medicine as a Treatment for Resistant Hypertension.生活方式医学作为难治性高血压的治疗方法。
Curr Hypertens Rep. 2023 Oct;25(10):313-328. doi: 10.1007/s11906-023-01253-5. Epub 2023 Jul 20.
7
Characterization of Individuals With Apparent Resistant Hypertension Using Contemporary Guidelines: Insights From CV-QUIC.利用当代指南对明显耐药性高血压患者进行特征描述:来自 CV-QUIC 的见解。
Hypertension. 2023 Sep;80(9):1845-1855. doi: 10.1161/HYPERTENSIONAHA.123.20894. Epub 2023 Jun 26.
8
Bibliometric analysis of stroke and quality of life.中风与生活质量的文献计量分析
Front Neurol. 2023 Apr 11;14:1143713. doi: 10.3389/fneur.2023.1143713. eCollection 2023.
9
Adverse cardiac remodeling is absent in patients with true controlled resistant hypertension.真正得到控制的耐药性高血压患者不存在不良心脏重构。
J Clin Hypertens (Greenwich). 2023 May;25(5):416-425. doi: 10.1111/jch.14625. Epub 2023 Apr 3.
10
Apparent treatment-resistant hypertension associated lifetime cardiovascular risk in a longitudinal national registry.在一个纵向国家注册研究中,与明显的治疗抵抗性高血压相关的终生心血管风险。
Eur J Prev Cardiol. 2023 Aug 1;30(10):960-968. doi: 10.1093/eurjpc/zwad066.

本文引用的文献

1
Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality.貌似难治性高血压与中风、冠心病及全因死亡率风险
J Am Soc Hypertens. 2014 Jun;8(6):405-13. doi: 10.1016/j.jash.2014.03.003. Epub 2014 Mar 15.
2
Prevalence, predictors, and outcomes in treatment-resistant hypertension in patients with coronary disease.冠心病患者中治疗抵抗性高血压的患病率、预测因素和结局。
Am J Med. 2014 Jan;127(1):71-81.e1. doi: 10.1016/j.amjmed.2013.07.038. Epub 2013 Nov 7.
3
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).2013年欧洲高血压学会(ESH)和欧洲心脏病学会(ESC)动脉高血压管理指南:欧洲高血压学会(ESH)和欧洲心脏病学会(ESC)动脉高血压管理特别工作组
J Hypertens. 2013 Jul;31(7):1281-357. doi: 10.1097/01.hjh.0000431740.32696.cc.
4
Resistant hypertension and the neglected antihypertensive: sodium restriction.耐药性高血压与被忽视的降压药:钠限制。
Nephrol Dial Transplant. 2012 Nov;27(11):4041-5. doi: 10.1093/ndt/gfs384. Epub 2012 Aug 16.
5
Aerobic exercise reduces blood pressure in resistant hypertension.有氧运动可降低抗药性高血压患者的血压。
Hypertension. 2012 Sep;60(3):653-8. doi: 10.1161/HYPERTENSIONAHA.112.197780. Epub 2012 Jul 16.
6
The impact of physical activity on mortality in patients with high blood pressure: a systematic review.体力活动对高血压患者死亡率的影响:系统评价。
J Hypertens. 2012 Jul;30(7):1277-88. doi: 10.1097/HJH.0b013e3283544669.
7
Incidence and prognosis of resistant hypertension in hypertensive patients.高血压患者中耐药性高血压的发生率和预后。
Circulation. 2012 Apr 3;125(13):1635-42. doi: 10.1161/CIRCULATIONAHA.111.068064. Epub 2012 Feb 29.
8
Resistant hypertension.顽固性高血压
Heart. 2012 Feb;98(3):254-61. doi: 10.1136/heartjnl-2011-300741.
9
Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008.美国 1988 年至 2008 年期间不受控制且明显的治疗抵抗性高血压。
Circulation. 2011 Aug 30;124(9):1046-58. doi: 10.1161/CIRCULATIONAHA.111.030189. Epub 2011 Aug 8.
10
Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis.饮酒与某些心血管疾病结局的关联:系统评价和荟萃分析。
BMJ. 2011 Feb 22;342:d671. doi: 10.1136/bmj.d671.

健康生活方式因素与治疗抵抗性高血压患者心血管事件和死亡风险:卒中地理和种族差异研究。

Healthy lifestyle factors and risk of cardiovascular events and mortality in treatment-resistant hypertension: the Reasons for Geographic and Racial Differences in Stroke study.

机构信息

From the Department of Medicine, Columbia University Medical Center, New York, NY (K.M.D., D.S.); and Departments of Epidemiology (J.N.B., M.R.I., P.M.), Biostatistics (G.H.), and Medicine (D.A.C., M.M.S.), University of Alabama at Birmingham.

出版信息

Hypertension. 2014 Sep;64(3):465-71. doi: 10.1161/HYPERTENSIONAHA.114.03565. Epub 2014 Jun 9.

DOI:10.1161/HYPERTENSIONAHA.114.03565
PMID:24914189
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4134352/
Abstract

Few data exist on whether healthy lifestyle factors are associated with better prognosis among individuals with apparent treatment-resistant hypertension, a high-risk phenotype of hypertension. The purpose of this study was to assess the association of healthy lifestyle factors with cardiovascular events, all-cause mortality, and cardiovascular mortality among individuals with apparent treatment-resistant hypertension. We studied participants (n=2043) from the population-based Reasons for Geographic and Racial Differences in Stroke (REGARDS) study with apparent treatment-resistant hypertension (blood pressure ≥140/90 mm Hg despite the use of 3 antihypertensive medication classes or the use of ≥4 classes of antihypertensive medication regardless of blood pressure control). Six healthy lifestyle factors adapted from guidelines for the management of hypertension (normal waist circumference, physical activity ≥4 times/week, nonsmoking, moderate alcohol consumption, high Dietary Approaches to Stop Hypertension diet score, and low sodium-to-potassium intake ratio) were examined. A greater number of healthy lifestyle factors were associated with lower risk for cardiovascular events (n=360) during a mean follow-up of 4.5 years. Multivariable-adjusted hazard ratios [HR (95% confidence interval)] for cardiovascular events comparing individuals with 2, 3, and 4 to 6 versus 0 to 1 healthy lifestyle factors were 0.91 (0.68-1.21), 0.80 (0.57-1.14), and 0.63 (0.41-0.95), respectively (P-trend=0.020). Physical activity and nonsmoking were individual healthy lifestyle factors significantly associated with lower risk for cardiovascular events. Similar associations were observed between healthy lifestyle factors and risk for all-cause and cardiovascular mortality. In conclusion, healthy lifestyle factors, particularly physical activity and nonsmoking, are associated with a lower risk for cardiovascular events and mortality among individuals with apparent treatment-resistant hypertension.

摘要

关于健康的生活方式因素是否与明显治疗抵抗性高血压(高血压的一种高危表型)患者的预后改善相关,目前仅有少量数据。本研究旨在评估健康生活方式因素与明显治疗抵抗性高血压患者心血管事件、全因死亡率和心血管死亡率之间的关联。我们研究了来自基于人群的地理和种族差异导致中风原因(REGARDS)研究的参与者(n=2043),这些患者有明显的治疗抵抗性高血压(尽管使用了 3 种降压药物类别,或使用了≥4 种降压药物类别,而不管血压控制情况如何,血压仍≥140/90mmHg)。从高血压管理指南中选取了 6 种健康生活方式因素(正常腰围、每周运动≥4 次、不吸烟、适量饮酒、高得舒饮食评分和低钠钾摄入比)进行研究。在平均随访 4.5 年后,有更多健康生活方式因素与心血管事件(n=360)风险降低相关。与 0-1 个健康生活方式因素相比,比较 2、3 和 4-6 个健康生活方式因素的个体心血管事件的多变量调整后危险比(HR[95%置信区间])分别为 0.91(0.68-1.21)、0.80(0.57-1.14)和 0.63(0.41-0.95)(P趋势=0.020)。体力活动和不吸烟是与心血管事件风险降低显著相关的个别健康生活方式因素。在健康生活方式因素与全因死亡率和心血管死亡率之间也观察到了类似的关联。总之,健康的生活方式因素,特别是体力活动和不吸烟,与明显治疗抵抗性高血压患者心血管事件和死亡率的降低相关。